Importantly, we previously demonstrated that the combination of radiotherapy and CD137 costimulation was significantly more effective than each treatment alone in improving survival of mice with the intracranial GL261 glioma achieving tumor eradication in the majority of mice [38]. This evidence concerns the gene TNFRSF9 and central nervous system cancer.